Systematic sampling during MRI-US fusion prostate biopsy can overcome errors of targeting—prospective single center experience after 300 cases in first biopsy setting

BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy have become an integral part of the diagnosis of prostate cancer (PCa), as recommended by the European Association of Urology Guidelines. The aim of the current study was to evaluate the performance of MRI and MRI-tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Cata, Emanuel, Andras, Iulia, Ferro, Matteo, Kadula, Pierre, Leucuta, Daniel, Musi, Gennaro, Matei, Deliu-Victor, De Cobelli, Ottavio, Tamas-Szora, Attila, Caraiani, Cosmin, Lebovici, Andrei, Epure, Flavia, Bungardean, Maria, Coman, Radu-Tudor, Crisan, Nicolae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807351/
https://www.ncbi.nlm.nih.gov/pubmed/33457225
http://dx.doi.org/10.21037/tau-20-1001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807351/
https://www.ncbi.nlm.nih.gov/pubmed/33457225
http://dx.doi.org/10.21037/tau-20-1001

Ejemplares similares